Subsequently, FHL1 was shown to block HIF1α-HIF1β heterodimerization for regulation of HIF1 activity in hepatocellular carcinoma cells, leading to decreased promoter activity and expression of vascular endothelial growth factor (VEGF), an important target gene of HIF1α54. This evidence concerns the gene VEGFA and hepatocellular carcinoma.